BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17226959)

  • 1. Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity.
    Standley SM; Mende I; Goh SL; Kwon YJ; Beaudette TT; Engleman EG; Fréchet JM
    Bioconjug Chem; 2007; 18(1):77-83. PubMed ID: 17226959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
    Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
    ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
    Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates.
    Wille-Reece U; Flynn BJ; Loré K; Koup RA; Kedl RM; Mattapallil JJ; Weiss WR; Roederer M; Seder RA
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15190-4. PubMed ID: 16219698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
    Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
    Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants.
    White PJ; Anastasopoulos F; Church JE; Kuo CY; Boyd BJ; Hickey PL; Tu LS; Burns P; Lew AM; Heath WR; Davey GM; Pouton CW
    Vaccine; 2008 Dec; 26(52):6824-31. PubMed ID: 18948160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
    J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminarin-mediated targeting to Dectin-1 enhances antigen-specific immune responses.
    Xie J; Guo L; Ruan Y; Zhu H; Wang L; Zhou L; Yun X; Gu J
    Biochem Biophys Res Commun; 2010 Jan; 391(1):958-62. PubMed ID: 19962962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of protein-loaded hydrogel particles in an aqueous two-phase system for coincident antigen and CpG oligonucleotide delivery to antigen-presenting cells.
    Jain S; Yap WT; Irvine DJ
    Biomacromolecules; 2005; 6(5):2590-600. PubMed ID: 16153096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
    Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S
    Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L.
    Buonocore S; Haddou NO; Moore F; Florquin S; Paulart F; Heirman C; Thielemans K; Goldman M; Flamand V
    J Leukoc Biol; 2008 Sep; 84(3):713-20. PubMed ID: 18567840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T-cell tolerance can be broken by an adenoviral vaccine while CD4+ T-cell tolerance is broken by additional co-administration of a Toll-like receptor ligand.
    Salucci V; Mennuni C; Calvaruso F; Cerino R; Neuner P; Ciliberto G; La Monica N; Scarselli E
    Scand J Immunol; 2006 Jan; 63(1):35-41. PubMed ID: 16398699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity.
    Heit A; Schmitz F; Haas T; Busch DH; Wagner H
    Eur J Immunol; 2007 Aug; 37(8):2063-74. PubMed ID: 17628858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of antigen-specific cytotoxic T lymphocytes by immunization with negatively charged soluble antigen through scavenger receptor-mediated delivery.
    Yamasaki Y; Ikenaga T; Otsuki T; Nishikawa M; Takakura Y
    Vaccine; 2007 Jan; 25(1):85-91. PubMed ID: 16956699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diesel exhaust particles on antigen-presenting cells and antigen-specific Th immunity in mice.
    Inoue K; Koike E; Takano H; Yanagisawa R; Ichinose T; Yoshikawa T
    Exp Biol Med (Maywood); 2009 Feb; 234(2):200-9. PubMed ID: 19064938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.